title: Decentralizing postabortion care in Senegal with misoprostol for incomplete abortion.
abstract: OBJECTIVE
  To expand access to postabortion care (PAC) services in Senegal by introducing misoprostol as a first-line treatment at the community level.
  
  
  METHODS
  The present prospective study enrolled 481 women seeking treatment for incomplete abortion at 11 community health posts in Senegal between September 2011 and August 2012. Participants were given 400 μg of sublingual misoprostol and asked to return to the clinic 1 week later to confirm clinical status. At study completion, all women were asked to respond to a series of questions regarding their experience with this method. All care was provided by nurse midwives.
  
  
  RESULTS
  All but three of the study women (99.4%; 474/477) had successful complete abortion after taking misoprostol. Almost all women were satisfied or very satisfied with the treatment (99.6%; 469/471), would select the method again if needed (98.9%; 465/470), and would recommend the method to a friend (99.8%; 468/469).
  
  
  CONCLUSIONS
  The results provide further evidence that 400 μg of misoprostol is highly effective for first-line treatment of incomplete abortion. Furthermore, this regimen can be fully provided by nurse midwives, and can be easily and successfully introduced in community health settings where other methods of PAC may not previously have been available. Clinicaltrials.gov: NCT01939457.
authors.affiliation: Cabinet Medical Asta Seck, Pikine, Senegal.
authors.forename: Alioune
authors.initials: A
authors.lastname: Gaye
authors.affiliation: Gynuity Health Projects, NY, USA. Electronic address: adiop@gynuity.org.
authors.forename: Ayisha
authors.initials: A
authors.lastname: Diop
authors.affiliation: Gynuity Health Projects, NY, USA.
authors.forename: Tara
authors.initials: T
authors.lastname: Shochet
authors.affiliation: Gynuity Health Projects, NY, USA.
authors.forename: Beverly
authors.initials: B
authors.lastname: Winikoff
mesh_terms: D000020:Abortifacient Agents, Nonsteroidal / Q000008:administration & dosage*; D000027:Abortion, Incomplete / Q000188:drug therapy*; D000286:Administration, Sublingual; D000293:Adolescent; D000328:Adult; D005260:Female; D006297:Health Services Accessibility; D006801:Humans; D008429:Maternal Welfare; D008875:Middle Aged; D008880:Midwifery; D016595:Misoprostol / Q000008:administration & dosage*; D017060:Patient Satisfaction; D011247:Pregnancy; D011446:Prospective Studies; D012675:Senegal; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
chemical_list: D000020:Abortifacient Agents, Nonsteroidal; D016595:Misoprostol
keywords: Incomplete abortion; Misoprostol; Postabortion care; Senegal